Dr. Moheb S. Abdelmalek, MD

Dr. Abdelmalek practices at St. Luke's Hospital - Easton Campus in Easton, Pennsylvania, part of St. Luke's University Health Network.

Dr. Abdelmalek's NPI, 1699776179, was assigned on August 9, 2005. Dr. Abdelmalek holds New Jersey license 25MA06009600.

Dr. Abdelmalek's primary practice is St. Luke's Hospital - Easton Campus, at 250 South 21st Street, Easton, PA 18042 in Northampton County. The practice phone is (610) 250-4076.

Dr. Abdelmalek's primary practice is St. Luke's Hospital - Easton Campus in Easton, Pennsylvania, part of St. Luke's University Health Network. Dr. Abdelmalek is also affiliated with Raritan Bay Medical Center. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Abdelmalek to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdelmalek practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Abdelmalek's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Abdelmalek's licenses on file in 2 states: New Jersey and Pennsylvania.

CMS data shows 269 Medicare services from Dr. Abdelmalek across 3 procedure codes in 2024, for 259 Medicare patients. Medicare paid $33,886 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 259 Medicare patients who saw Dr. Abdelmalek in 2024. The largest group is 65 to 74, with 91 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdelmalek's median patient age at 57, with 52% women.

In 2024, Dr. Abdelmalek wrote 155 Medicare Part D claims for 114 patients. 96% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $46 in total drug cost. In 2023, CMS named 23 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Abdelmalek for performance year 2024, reported through an alternative payment model (APM). Dr. Abdelmalek accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Abdelmalek from 1 drug or device company from 2017 to 2019. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $28.